View Future GrowthHanil Chemical Ind 과거 순이익 실적과거 기준 점검 0/6Hanil Chemical Ind 의 수입은 연평균 -56.3%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 0.3%의 비율로 감소했습니다. 매출은 연평균 1.8%의 비율로 증가해 왔습니다.핵심 정보-56.28%순이익 성장률-56.23%주당순이익(EPS) 성장률Chemicals 산업 성장률13.95%매출 성장률1.78%자기자본이익률-22.19%순이익률-13.43%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩730 loss per share (vs ₩661 loss in 3Q 2023)Third quarter 2024 results: ₩730 loss per share (further deteriorated from ₩661 loss in 3Q 2023). Revenue: ₩31.9b (up 14% from 3Q 2023). Net loss: ₩2.56b (loss widened 10% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩157 loss per share (vs ₩758 loss in 2Q 2023)Second quarter 2024 results: ₩157 loss per share (improved from ₩758 loss in 2Q 2023). Revenue: ₩31.5b (down 1.3% from 2Q 2023). Net loss: ₩553.6m (loss narrowed 79% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 22Full year 2023 earnings released: ₩3,477 loss per share (vs ₩1,468 profit in FY 2022)Full year 2023 results: ₩3,477 loss per share (down from ₩1,468 profit in FY 2022). Revenue: ₩121.9b (down 22% from FY 2022). Net loss: ₩12.2b (down 337% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.모든 업데이트 보기Recent updates공시 • Feb 12Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2026Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 47, sandan 3-ro 6-gil, seongmun-myeon, chungcheongnam-do, dangjin South KoreaUpcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 20 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).Declared Dividend • Nov 08Dividend of ₩50.00 announcedDividend of ₩50.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 20th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments.공시 • Nov 07Hanil Chemical Ind. Co., Ltd. announces Annual dividend, payable on April 20, 2026Hanil Chemical Ind. Co., Ltd. announced Annual dividend of KRW 50.0000 per share payable on April 20, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.분석 기사 • Apr 08Hanil Chemical Ind. Co., Ltd.'s (KOSDAQ:007770) Popularity With Investors Is Under Threat From OverpricingWith a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Korea, you could be...공시 • Feb 14Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2025Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 47, sandan 3-ro 6-gil, seongmun-myeon, chungcheongnam-do, dangjin South Korea분석 기사 • Feb 05Hanil Chemical Ind (KOSDAQ:007770) Is Making Moderate Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Upcoming Dividend • Dec 20Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 28 April 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).New Risk • Dec 07New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2012. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2012 fiscal period end). Minor Risk Market cap is less than US$100m (₩33.7b market cap, or US$23.7m).Declared Dividend • Nov 23Dividend of ₩50.00 announcedShareholders will receive a dividend of ₩50.00. Ex-date: 27th December 2024 Payment date: 28th April 2025 Dividend yield will be 0.5%, which is lower than the industry average of 1.7%.Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩730 loss per share (vs ₩661 loss in 3Q 2023)Third quarter 2024 results: ₩730 loss per share (further deteriorated from ₩661 loss in 3Q 2023). Revenue: ₩31.9b (up 14% from 3Q 2023). Net loss: ₩2.56b (loss widened 10% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩157 loss per share (vs ₩758 loss in 2Q 2023)Second quarter 2024 results: ₩157 loss per share (improved from ₩758 loss in 2Q 2023). Revenue: ₩31.5b (down 1.3% from 2Q 2023). Net loss: ₩553.6m (loss narrowed 79% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 6.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩48.1b market cap, or US$35.3m).Reported Earnings • Mar 22Full year 2023 earnings released: ₩3,477 loss per share (vs ₩1,468 profit in FY 2022)Full year 2023 results: ₩3,477 loss per share (down from ₩1,468 profit in FY 2022). Revenue: ₩121.9b (down 22% from FY 2022). Net loss: ₩12.2b (down 337% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.Upcoming Dividend • Dec 20Upcoming dividend of ₩100.00 per share at 0.6% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₩26,700, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 180% over the past three years.Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 51%After last week's 51% share price gain to ₩31,250, the stock trades at a trailing P/E ratio of 25.3x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 243% over the past three years.Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 38%After last week's 38% share price gain to ₩22,950, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 166% over the past three years.Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 1.5% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Oct 26Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩19,750, the stock trades at a trailing P/E ratio of 2.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 52% over the past three years.Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₩26,000, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past three years.Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩27,450, the stock trades at a trailing P/E ratio of 3.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 81% over the past three years.Valuation Update With 7 Day Price Move • Aug 23Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₩23,750, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 43% over the past three years.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩21,700, the stock trades at a trailing P/E ratio of 3.3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 88% over the past three years.Valuation Update With 7 Day Price Move • Jun 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩19,950, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 64% over the past three years.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩22,200, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₩22,200, the stock trades at a trailing P/E ratio of 27.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 90% over the past three years.Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩15,500, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 41% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 19 April 2022. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%).Valuation Update With 7 Day Price Move • Nov 30Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to ₩14,350, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 37% over the past three years.Valuation Update With 7 Day Price Move • Oct 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩19,550, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 71% over the past three years.Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩15,000, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 27% over the past three years.분석 기사 • Apr 08Is Hanil Chemical Ind (KOSDAQ:007770) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Mar 10New 90-day high: ₩16,800The company is up 78% from its price of ₩9,430 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period.분석 기사 • Mar 04Is Hanil Chemical Ind. Co., Ltd. (KOSDAQ:007770) A Good Dividend Stock?Is Hanil Chemical Ind. Co., Ltd. ( KOSDAQ:007770 ) a good dividend stock? How can we tell? Dividend paying companies...공시 • Feb 10Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 25, 2021Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 25, 2021, at 09:00 Korea Standard Time.Is New 90 Day High Low • Jan 04New 90-day high: ₩10,550The company is up 20% from its price of ₩8,820 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.Is New 90 Day High Low • Dec 09New 90-day high: ₩9,450The company is up 3.0% from its price of ₩9,190 on 10 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Is New 90 Day High Low • Nov 20New 90-day high: ₩9,400The company is up 6.0% from its price of ₩8,900 on 21 August 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.분석 기사 • Nov 19Are Dividend Investors Making A Mistake With Hanil Chemical Ind. Co., Ltd. (KOSDAQ:007770)?Dividend paying stocks like Hanil Chemical Ind. Co., Ltd. (KOSDAQ:007770) tend to be popular with investors, and for...Is New 90 Day High Low • Sep 24New 90-day low: ₩8,560The company is down 10.0% from its price of ₩9,530 on 26 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 29% over the same period.매출 및 비용 세부 내역Hanil Chemical Ind가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A007770 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Mar 26127,450-17,12210,47639831 Dec 25124,410-18,33110,22529430 Sep 25126,896-5,86610,84856730 Jun 25128,635-4,66411,23767331 Mar 25128,866-1,48710,92277431 Dec 24125,282-2,00910,96284330 Sep 24120,465-10,62310,37483230 Jun 24116,551-10,38310,32480931 Mar 24116,972-12,48810,88158231 Dec 23121,936-12,2069,91884530 Sep 23128,344-8,6589,87580230 Jun 23139,239-4,18210,47559131 Mar 23151,4741,8549,67781631 Dec 22155,5615,15410,16877730 Sep 22151,63727,79212,75784730 Jun 22140,53825,64011,06584731 Mar 22125,83623,20910,04978531 Dec 21113,92822,6949,00470330 Sep 21108,7822,8434,83759630 Jun 21102,5472,4294,71259631 Mar 2190,139-6154,23057631 Dec 2086,793-1,3125,87256830 Sep 2084,073-2,3366,17159730 Jun 2087,817-1,9096,17759731 Mar 20100,6581,4486,58559431 Dec 19108,7201,6694,56356530 Sep 19118,1911,8254,83653330 Jun 19130,1261,9004,75253331 Mar 19144,5582,2824,52156531 Dec 18152,8612,8444,37359930 Sep 18161,3493,1604,24260030 Jun 18169,5653,7364,28660031 Mar 18158,7663,1464,35456131 Dec 17151,8803,3404,40951730 Sep 17152,7096,0084,55150930 Jun 17143,1864,4944,51850931 Mar 17148,6194,5494,50951531 Dec 16146,7573,1794,57951130 Sep 16128,163-5784,42753130 Jun 16118,4371,4654,36553131 Mar 16109,4901,1284,40549731 Dec 15107,2031,5914,41948230 Sep 15112,4613,7004,84946730 Jun 15114,6312,6594,793467양질의 수익: A007770 은(는) 현재 수익성이 없습니다.이익 마진 증가: A007770는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A007770은 수익성이 없으며 지난 5년 동안 손실이 연평균 56.3% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A007770의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A007770은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-3.5%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A007770는 현재 수익성이 없으므로 자본 수익률이 음수(-22.19%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/14 11:52종가2026/06/12 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Hanil Chemical Ind. Co., Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩730 loss per share (vs ₩661 loss in 3Q 2023)Third quarter 2024 results: ₩730 loss per share (further deteriorated from ₩661 loss in 3Q 2023). Revenue: ₩31.9b (up 14% from 3Q 2023). Net loss: ₩2.56b (loss widened 10% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩157 loss per share (vs ₩758 loss in 2Q 2023)Second quarter 2024 results: ₩157 loss per share (improved from ₩758 loss in 2Q 2023). Revenue: ₩31.5b (down 1.3% from 2Q 2023). Net loss: ₩553.6m (loss narrowed 79% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 22Full year 2023 earnings released: ₩3,477 loss per share (vs ₩1,468 profit in FY 2022)Full year 2023 results: ₩3,477 loss per share (down from ₩1,468 profit in FY 2022). Revenue: ₩121.9b (down 22% from FY 2022). Net loss: ₩12.2b (down 337% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
공시 • Feb 12Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2026Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: auditorium, 47, sandan 3-ro 6-gil, seongmun-myeon, chungcheongnam-do, dangjin South Korea
Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 20 April 2026. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
Declared Dividend • Nov 08Dividend of ₩50.00 announcedDividend of ₩50.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 20th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 66 years, indicating a lack of growth and stability in payments.
공시 • Nov 07Hanil Chemical Ind. Co., Ltd. announces Annual dividend, payable on April 20, 2026Hanil Chemical Ind. Co., Ltd. announced Annual dividend of KRW 50.0000 per share payable on April 20, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
분석 기사 • Apr 08Hanil Chemical Ind. Co., Ltd.'s (KOSDAQ:007770) Popularity With Investors Is Under Threat From OverpricingWith a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Korea, you could be...
공시 • Feb 14Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2025Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:01 Tokyo Standard Time. Location: auditorium, 47, sandan 3-ro 6-gil, seongmun-myeon, chungcheongnam-do, dangjin South Korea
분석 기사 • Feb 05Hanil Chemical Ind (KOSDAQ:007770) Is Making Moderate Use Of DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Upcoming Dividend • Dec 20Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 28 April 2025. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
New Risk • Dec 07New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2012. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported September 2012 fiscal period end). Minor Risk Market cap is less than US$100m (₩33.7b market cap, or US$23.7m).
Declared Dividend • Nov 23Dividend of ₩50.00 announcedShareholders will receive a dividend of ₩50.00. Ex-date: 27th December 2024 Payment date: 28th April 2025 Dividend yield will be 0.5%, which is lower than the industry average of 1.7%.
Reported Earnings • Nov 20Third quarter 2024 earnings released: ₩730 loss per share (vs ₩661 loss in 3Q 2023)Third quarter 2024 results: ₩730 loss per share (further deteriorated from ₩661 loss in 3Q 2023). Revenue: ₩31.9b (up 14% from 3Q 2023). Net loss: ₩2.56b (loss widened 10% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩157 loss per share (vs ₩758 loss in 2Q 2023)Second quarter 2024 results: ₩157 loss per share (improved from ₩758 loss in 2Q 2023). Revenue: ₩31.5b (down 1.3% from 2Q 2023). Net loss: ₩553.6m (loss narrowed 79% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
New Risk • May 23New major risk - Revenue and earnings growthEarnings have declined by 6.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.5% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩48.1b market cap, or US$35.3m).
Reported Earnings • Mar 22Full year 2023 earnings released: ₩3,477 loss per share (vs ₩1,468 profit in FY 2022)Full year 2023 results: ₩3,477 loss per share (down from ₩1,468 profit in FY 2022). Revenue: ₩121.9b (down 22% from FY 2022). Net loss: ₩12.2b (down 337% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has remained flat, which means it is well ahead of earnings.
Upcoming Dividend • Dec 20Upcoming dividend of ₩100.00 per share at 0.6% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 15 April 2024. The company is not currently making a profit and is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₩26,700, the stock trades at a trailing P/E ratio of 43x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 180% over the past three years.
Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 51%After last week's 51% share price gain to ₩31,250, the stock trades at a trailing P/E ratio of 25.3x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 243% over the past three years.
Valuation Update With 7 Day Price Move • Apr 13Investor sentiment improves as stock rises 38%After last week's 38% share price gain to ₩22,950, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 166% over the past three years.
Upcoming Dividend • Dec 21Upcoming dividend of ₩120 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is a comfortable 1.5% but the company is not cash flow positive. Trailing yield: 0.7%. Lower than top quartile of South Korean dividend payers (3.3%). Lower than average of industry peers (2.4%).
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Oct 26Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩19,750, the stock trades at a trailing P/E ratio of 2.7x. Average trailing P/E is 12x in the Chemicals industry in South Korea. Total returns to shareholders of 52% over the past three years.
Valuation Update With 7 Day Price Move • Sep 22Investor sentiment deteriorated over the past weekAfter last week's 26% share price decline to ₩26,000, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past three years.
Valuation Update With 7 Day Price Move • Sep 07Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩27,450, the stock trades at a trailing P/E ratio of 3.8x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 81% over the past three years.
Valuation Update With 7 Day Price Move • Aug 23Investor sentiment improved over the past weekAfter last week's 20% share price gain to ₩23,750, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 43% over the past three years.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩21,700, the stock trades at a trailing P/E ratio of 3.3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 88% over the past three years.
Valuation Update With 7 Day Price Move • Jun 21Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₩19,950, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 64% over the past three years.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Apr 01Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩22,200, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 15x in the Chemicals industry in South Korea. Total returns to shareholders of 99% over the past three years.
Valuation Update With 7 Day Price Move • Mar 02Investor sentiment improved over the past weekAfter last week's 21% share price gain to ₩22,200, the stock trades at a trailing P/E ratio of 27.4x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 90% over the past three years.
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩15,500, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 41% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩50.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 19 April 2022. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.3%. Lower than top quartile of South Korean dividend payers (2.4%). Lower than average of industry peers (1.5%).
Valuation Update With 7 Day Price Move • Nov 30Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to ₩14,350, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 37% over the past three years.
Valuation Update With 7 Day Price Move • Oct 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to ₩19,550, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 20x in the Chemicals industry in South Korea. Total returns to shareholders of 71% over the past three years.
Valuation Update With 7 Day Price Move • Oct 06Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩15,000, the stock trades at a trailing P/E ratio of 21.7x. Average trailing P/E is 19x in the Chemicals industry in South Korea. Total returns to shareholders of 27% over the past three years.
분석 기사 • Apr 08Is Hanil Chemical Ind (KOSDAQ:007770) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Mar 10New 90-day high: ₩16,800The company is up 78% from its price of ₩9,430 on 10 December 2020. The South Korean market is up 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 7.0% over the same period.
분석 기사 • Mar 04Is Hanil Chemical Ind. Co., Ltd. (KOSDAQ:007770) A Good Dividend Stock?Is Hanil Chemical Ind. Co., Ltd. ( KOSDAQ:007770 ) a good dividend stock? How can we tell? Dividend paying companies...
공시 • Feb 10Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 25, 2021Hanil Chemical Ind. Co., Ltd., Annual General Meeting, Mar 25, 2021, at 09:00 Korea Standard Time.
Is New 90 Day High Low • Jan 04New 90-day high: ₩10,550The company is up 20% from its price of ₩8,820 on 06 October 2020. The South Korean market is up 21% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 22% over the same period.
Is New 90 Day High Low • Dec 09New 90-day high: ₩9,450The company is up 3.0% from its price of ₩9,190 on 10 September 2020. The South Korean market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Is New 90 Day High Low • Nov 20New 90-day high: ₩9,400The company is up 6.0% from its price of ₩8,900 on 21 August 2020. The South Korean market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
분석 기사 • Nov 19Are Dividend Investors Making A Mistake With Hanil Chemical Ind. Co., Ltd. (KOSDAQ:007770)?Dividend paying stocks like Hanil Chemical Ind. Co., Ltd. (KOSDAQ:007770) tend to be popular with investors, and for...
Is New 90 Day High Low • Sep 24New 90-day low: ₩8,560The company is down 10.0% from its price of ₩9,530 on 26 June 2020. The South Korean market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 29% over the same period.